|  Help  |  About  |  Contact Us

Publication : The fusion partner specifies the oncogenic potential of NUP98 fusion proteins.

First Author  Saw J Year  2013
Journal  Leuk Res Volume  37
Issue  12 Pages  1668-73
PubMed ID  24090997 Mgi Jnum  J:320505
Mgi Id  MGI:6872798 Doi  10.1016/j.leukres.2013.09.013
Citation  Saw J, et al. (2013) The fusion partner specifies the oncogenic potential of NUP98 fusion proteins. Leuk Res 37(12):1668-73
abstractText  NUP98 is among the most promiscuously translocated genes in hematological diseases. Among the 28 known fusion partners, there are two categories: homeobox genes and non-homeobox genes. The homeobox fusion partners are well-studied in animal models, resulting in HoxA cluster overexpression and hematological disease. The non-homeobox fusion partners are less well studied. We created transgenic animal models for three NUP98 fusion genes (one homeobox, two non-homeobox), and show that in this system, the NUP98-homeobox fusion promotes self-renewal and aberrant gene expression to a significantly greater extent. We conclude that homeobox partners create more potent NUP98 fusion oncogenes than do non-homeobox partners.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression